Demonstration that FMD was improved, and oxidative stress was reduced, in SDB children following AT, additionally support NOX2′s role in endothelial dysfunction and its inhibition as a promising therapeutic approach [58]. The gene discussed is CYBB; the disease is endothelial dysfunction.